alvotech.com (ALVO): Net earnings per share growth forecast for next year
Alvotech demonstrates a high level of operational control and transparency regarding its regulatory plans. The estimated growth in net income per share for the coming year clearly illustrates the trend of expert expectations, where the 2256.40 mark serves as the current indicator. The issuer remains independent of macro cycles due to its portfolio commercialization, while full vertical integration enables the company to release affordable biosimilars faster than industry behemoths.
Comprehensive metric breakdowns and analytics for alvotech.com (ALVO)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
ALVO - Net Income|Projected Future Earnings Alvotech|ALVO - Company Value to Net Income|Forward P/E Multiple Alvotech|ALVO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alvotech|ALVO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Alvotech|ALVO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months alvotech.com|ALVO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Alvotech
Fundamental company analysis:Alvotech Corp
This indicator assesses business adaptability to the cost of capital by analyzing institutional investors' expectations for profit dynamics. By examining the projected earnings per share (EPS) growth target, an analyst can determine the ratio of future net income to the number of shares, which for Alvotech (ALVO) reflects the scaling efficiency of its biosimilar portfolio and the speed of reaching operational profitability during global expansion.
Direct competitors
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year LGND (Ligand)|Earnings growth forecast for next year Amneal Pharmaceuticals, Inc. AMRX|PRGO - Net earnings per share growth forecast for next year|LQDA: Net earnings per share growth forecast for next year|GLPG (Galapagos NV) - Expected earnings per share growth for next year|ANIP (anipharmaceuticals.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year MannKind|Expected net earnings per share growth next year Amphastar Pharmaceuticals Inc AMPH|Expected earnings per share growth for next year PCRX (Pacira)|Projected earnings per share increase next year SPRY|Earnings growth forecast for next year TBPH (Theravance Biopharma)|aquestive.com (AQST) - Expected net earnings per share growth next year|scPharma - Earnings growth forecast for next year|Tectonic Therapeutic, Inc. (TECX) - Expected earnings per share growth for next year|TNXP: Earnings growth forecast for next year|China SXT Pharmaceuticals, Inc. - Expected earnings per share trend next year|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year bioharvest.com|Net earnings per share growth forecast for next year eXoZymes (EXOZ)|Net earnings per share growth forecast for next year ORMP (oramed.com)|Entera Bio - Expected earnings per share growth for next year|MindWalk Therapeutics - Net earnings per share growth forecast for next year|ABVC - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year cumberlandpharma.com|Quantum BioPharma (QNTM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year FGEN (FibroGen Inc)|TELO (Telomir Pharma) - Earnings growth forecast for next year|RANI: Expected earnings per share trend next year|Earnings growth forecast for next year SNYR|Earnings growth forecast for next year rallybio.com (RLYB)|Net earnings per share growth forecast for next year Lexaria Bioscience Corp. LEXX|Expected earnings per share trend next year PULM|PTHL - Net earnings per share growth forecast for next year|Aptorum Group Limited (APM) - Expected earnings per share growth for next year|LYRA: Earnings growth forecast for next year|Impact BioMedical, Inc. (IBO) - Earnings growth forecast for next year|Expected earnings per share growth for next year TNFA|YCBD: Expected earnings per share trend next year|Net earnings per share growth forecast for next year PainReform Limited (PRFX)|CYTO - Expected net earnings per share growth next year|Lipella Pharmaceuticals - Expected earnings per share growth for next year|Projected earnings per share increase next year OPTN (optinose.com)|Pieris Pharmaceuticals, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PROC (Procaps Group)|PTPI: Earnings growth forecast for next year|Expected net earnings per share growth next year Qilian International Corp (QLI)|Net earnings per share growth forecast for next year Acelyrin, Inc.|TFFP: Expected earnings per share trend next year
